Skip to content

The Role of Amniotic Membrane in Promoting Rapid Recovery of Buccal Mucosal Defect After Harvesting Oral Mucosa for Urethral Reconstruction

The Role of Amniotic Membrane in Promoting Rapid Recovery of Buccal Mucosal Defect After Harvesting Oral Mucosa for Urethral Reconstruction

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07824596
Enrollment
58
Registered
2026-09-17
Start date
2025-06-22
Completion date
2026-05-10
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Buccal Mucosal Defect

Keywords

Amniotic membrane, Buccal Mucosa, Buccal Mucosal Defect, Oral Mucosa Harvesting, Urethral Reconstruction, Oral Mucosal Wound Healing, Wound Healing

Brief summary

investigators use biological material to enhance recovery of oral cavity row area after harvesting a graft from it to use it in urethral reconstruction

Interventions

BIOLOGICALuse of amniotic membrane as a biological dressing over buccal mucosal raw area

use of amniotic membrane as a biological dressing over buccal mucosal raw area versus classic non closure technique after using BMG in urethroplasty for urethral stricture

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients were eligible for inclusion if they met the following criteria: * Adult patients (≥18 years) * Diagnosed with anterior urethral stricture requiring substitution urethroplasty * Planned use of buccal mucosal graft for urethral reconstruction * Ability to provide informed consent and comply with follow-up protocol

Exclusion criteria

* Patients were excluded if they had: * Previous buccal mucosal graft harvest * Active oral infection or mucosal pathology * History of oral malignancy or radiotherapy * Uncontrolled systemic disease (e.g., poorly controlled diabetes mellitus) * Immunosuppression or chronic steroid use * Known allergy to biological graft materials

Design outcomes

Primary

MeasureTime frameDescription
Postoperative donor-site epithelialization of the buccal donor site using Oral Mucosa Rating Scale (OMRS)from the first day post op to 12 weeksOral Mucosa Rating Scale (OMRS): visual assessment of oral mucosa erythema, ulceration granulation, suppuration, and edema. * Erythema (Redness): from (0) normal to (3) severe * Ulceration: from (0) normal to (3) severe * Granulation Tissue (Healing/Chronic Inflammation): from (0) normal to (3) severe * Suppuration (Pus/Infection): from (0) normal to (3) severe * Edema (Swelling): from (0) normal to (3) severe
• Postoperative donor-site epithelialization of the buccal donor site using Landry Healing Index (HI) Scorespost op week 1 and 4Landry Healing Index (HI) Scores (1-5). The HI scores wound healing on a 1-to-5 scale, where a higher score indicates better, more accelerated healing:
Postoperative donor-site epithelialization of the buccal donor site using Early wound healing scorepost op day 1EHS Component Breakdown (Total: 10 points): the higher the score indicate better healing * Clinical Signs of Re-epithelialization (CSR - 6 points max) * Clinical Signs of Hemostasis (CSH - 2 points max) * Clinical Signs of Inflammation (CSI - 2 points max)

Secondary

MeasureTime frameDescription
Postoperative pain assessed by Visual Analogue Scale (VAS)from first day post operative to 12 weeksassessed by Visual Analogue Scale (VAS): form (0) which means no pain to (10) which means severe pain
Degree of oral aperture restriction (trismus),Postoperative day 1 through week 12assessed by inter-incisor distance measurement
Oral health-related quality of lifePostoperative weeks 6 and 12assessed by Oral Health Impact Profile-14 (OHIP-14): higher scores indicate a more negative impact on your quality of life. Scoring Methods: There are two primary ways to calculate a score from the 5-point Likert scale (0 = Never, 1 = Hardly ever, 2 = Occasionally, 3 = Fairly often, 4 = Very often): * Additive Method: Sum the numerical values of all 14 answers. The total score ranges from 0 to 56. * Simple Count Method: Count the number of items where you answered "Occasionally" or more frequently. This score ranges from 0 to 14 and that's the method was used.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026